Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Quantum-Si announced a major milestone in its Proteus development program with successful detection of 19 amino acids, moving closer to the goal of detecting all 20 amino acids by the end of 2026. This progress is expected to enhance the performance of its single-molecule protein sequencing platform ahead of a planned commercial launch in Q2 2027.
Postal Realty Trust, Inc., a REIT specializing in logistics properties primarily leased to the US Postal Service, announced it will report its third quarter 2026 financial results on November 3, 2026. The company will hold a webcast and conference call on November 4 to discuss the results. Investors and analysts can access the event via live audio …
RoboStrategy, Inc. (Nasdaq: BOT), a closed-end fund focused on robotics and physical AI, announced it will host a robotics founders forum in New York City on October 13 featuring its portfolio companies. The event includes panel discussions and live robot demonstrations from leading robotics firms, culminating in RoboStrategy's CEO ringing the Nasd…
Alamar Biosciences, a Nasdaq-listed leader in Precision Proteomics, will report its third quarter 2026 financial results on November 3, 2026, after market close. The company will host a webcast and conference call to discuss its financial performance and provide updates to investors.
BCP Investment Corporation, a publicly traded business development company specializing in middle market investments, will release its third quarter 2026 financial results on November 5, 2026. A conference call to discuss these results is scheduled for November 6, 2026.
Fossil Group, Inc. has elected Sebastian DiGrande and Chandhu Nair to its Board of Directors, along with naming Wendy Schoppert as Chair of the Board. These appointments aim to enhance the company's strategic turnaround efforts, focusing on innovation, technology, and omnichannel commerce to drive long-term growth and shareholder value.
Exponent, Inc. announced it will report its third quarter fiscal year 2026 financial results on October 29, 2026. The company will hold a conference call and webcast with key executives to discuss business and financial performance. Exponent is a consulting firm specializing in technical and scientific services across multiple industries globally.
Pool Corporation, the world's largest wholesale distributor of swimming pool and backyard products, announced it will release its Q3 2026 earnings before market open on October 22, 2026, followed by a conference call to discuss the results.
NovaBridge Biosciences announced updated Phase 1b data on givastomig, a novel bispecific antibody targeting Claudin 18.2, combined with nivolumab and chemotherapy for first-line treatment of metastatic gastroesophageal adenocarcinoma. The data, to be presented at ESMO 2026, demonstrate promising safety, efficacy, and durability, supporting progress…
Applied Materials has announced a research partnership with UCLA Samueli School of Engineering at its EPIC Center in Silicon Valley to speed up semiconductor R&D and commercialization. This collaboration aims to shorten the time from breakthrough chip research to full-scale manufacturing, targeting advances in AI chip technologies, 3D chip scaling,…
AppFolio, Inc., a technology company serving the real estate industry, announced it will release its third quarter 2026 financial results after the U.S. market closes on October 22, 2026. The company will hold a conference call the same day to discuss results and business outlook, with live webcast and replay options available to investors.
Sezzle Inc., a Nasdaq-listed fintech company, announced it will release its third quarter 2026 financial results after market close on November 4, 2026, followed by a conference call and webcast. The company also plans to participate in several investor conferences throughout November and December to present its latest developments and financial ou…
NeuroOne Medical Technologies Corporation has secured a subaward agreement through a $1 million NIH grant led by Dartmouth College to advance next-generation neurotransmitter sensing technology. The initial funding provides NeuroOne approximately $200,000 through April 2027, supporting the integration of advanced neurochemical sensing with its neur…
Monolithic Power Systems, Inc. announced it will release its third quarter 2026 financial results on October 29, 2026 after market hours and host a Q&A webinar to discuss the results and outlook. The company is a fabless semiconductor provider specializing in power electronics solutions.
XORTX Therapeutics Inc. plans to file a Clinical Trial Application (CTA) with Health Canada for its XRx-026 gout treatment program, advancing its international regulatory strategy. This Canadian filing will enable faster clinical study execution and delivery of key data supporting a future New Drug Application (NDA) with the U.S. FDA, potentially a…
WTW (NASDAQ: WTW), a global advisory and broking company, will release its Q3 2026 financial results on October 29 before market open, followed by a conference call to discuss the results. The webcast and replay will be available for investors and analysts.
Tevogen Inc., a Nasdaq-listed healthcare company integrating biopharma, AI, and healthcare services, announced a signed non-binding Letter of Intent to evaluate a potential acquisition of HRK Healthcare LLC. The transaction aims to enhance Tevogen's healthcare services capabilities, supporting its goal to become a revenue-generating healthcare ente…
Moomoo Financial Inc. has expanded its account funding methods by partnering with Visa and Checkout.com to enable eligible users to make real-time deposits using Apple Pay and Google Pay around the clock. This collaboration enhances the speed and convenience for investors to quickly fund their accounts and access capital for trading stocks, cryptoc…
Synopsys is uniquely positioned to capture AI-driven demand for custom silicon. Recent strategic deals, investor guidance for revenue up to $11.2B in 2027 and a healthy free cash flow profile make a controlled long trade attractive. Entry at $498, stop at $460 and a target at $580 offers an asymmetric risk-reward over the next 45 trading days.
Integra Resources ($ITRG) is a rare mid-cap gold producer where the market appears to be paying chiefly for one permitted mine while giving optionality on a second project for free. With a $519M market cap, improving near-mine drilling at Florida Canyon and aggressive 2026 drilling plans leave room for meaningful re-rating if the company converts o…
Nano Nuclear Energy (NNE) has pulled back from its 52-week high and is trading near its 52-week low, but the company still carries meaningful cash, advancing reactor designs, and fresh defense and commercial interest. With a market cap around $807M and enterprise value near $561M, the risk/reward looks favorable for a mid-term swing trade while the…
FANUY (FANUC ADR) has a lot working in its favor right now: strategic commitments to Nvidia’s physical AI push, steady industry tailwinds for robotics and lasers, and improving near‑term technicals. At a market cap near $37B and a P/E around 31x, the stock is not dirt cheap, but recent data and sector catalysts justify a risk‑controlled long with c…
Customers Bancorp (CUBI) is trading at a sensible multiple, generating healthy free cash flow, and sitting well above last year's lows despite regulatory headwinds. We outline a mid-term swing trade with an entry at $74.50, a stop at $68.00, and a target of $84.00 over ~45 trading days.
Amazon is oversold relative to the structural upside coming from AI-driven cloud demand and continued retail resilience. At current levels, the stock offers a favorable risk-reward: a P/E near 21, ROE above 24%, and a $2.7T market cap that still leaves room for meaningful upside as AWS monetizes next-gen AI workloads. This trade proposes an entry a…
Arbutus (ABUS) currently trades at $4.18 with a market cap near $830M. Management’s $230M buyback announcement and the March 2026 Moderna settlement have meaningfully de-risked near-term liquidity and the litigation overhang. Combine that with positive imdusiran clinical signals and an attractive post-settlement valuation, and ABUS looks actionable…
